Find Rituximab manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

21RELATED EXCIPIENT COMPANIES

38EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

API REF. PRICE (USD/KG)

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set

API SUPPLIERS

read-more
read-more

01

LGM Pharma

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
LGM Pharma CB

02

Shanghai Minbiotech

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothShanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.

Flag China
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Shanghai Minbiotech CB

03

Beijing Mesochem Technology

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMesochem is focused on incessant innovation along with the R&D of new APIs.

Flag China
Digital Content Digital Content
USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT
Mesochem Company Banner

04

Biotechnica DWC

Algeria

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IOPC
Not Confirmed
arrow

05

Nanogen Pharmaceutical Biotechnolo...

Vietnam

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IOPC
Not Confirmed
arrow

06

Delphis Pharmaceutical India

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IOPC
Not Confirmed
arrow

07

Nanogen Pharmaceutical Biotechnolo...

Vietnam

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IOPC
Not Confirmed
arrow

08

Conscientia Industrial

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IOPC
Not Confirmed
arrow

09

KinBio

Israel

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

IOPC
Not Confirmed
arrow
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

LGM Pharma

U.S.A
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothLGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Flag U.S.A
Digital Content Digital Content

Rituximab

About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...

LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, analytical method development and testing, and commercial manufacturing. LGM Pharma offers custom API synthesis, analytical development, and regulatory services. With a network of over 300 accredited CGMP manufacturing partners, LGM provides unparalleled supply chain security. And, with over 100,000 square feet of FDA-inspected cGMP manufacturing and warehouse capacity, LGM Pharma provides a one-stop solution for solid dose, powder, semi-solid and liquid drugs.
LGM Pharma CB

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothShanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.

Flag China
Digital Content Digital Content

Rituximab

About the Company : ​Headquartered in Fengxian District, Shanghai Minbiotech Co., Ltd. is a company specializing in the R&D and production of advanced pharmaceutical intermediates and biological API...

​Headquartered in Fengxian District, Shanghai Minbiotech Co., Ltd. is a company specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square meters of R&D centers in Nantong, Jiangsu and Jinan, Shandong, with more than 13,000㎡ of production sites. While supplying products to customers, the company also provides services such as technology development, technology transfer and technology exchange, aiming to provide customers with comprehensive supply and solutions in the biomedical industry.
Shanghai Minbiotech CB

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothMesochem is focused on incessant innovation along with the R&D of new APIs.

Flag China
Digital Content Digital Content

Rituximab

About the Company : Beijing Mesochem Technology Co. Ltd., which is located in the national economic and technological development area of Yizhuang, China, manufactures pharmaceutical chemicals, fine c...

Beijing Mesochem Technology Co. Ltd., which is located in the national economic and technological development area of Yizhuang, China, manufactures pharmaceutical chemicals, fine chemicals and fundamental chemical materials. It has an efficient research and development team. Beijing Mesochem provides its customers customized development, craft optimization, contract customization and outsourcing services. The company has a well-established industrial base in Weinan, Shanxi Province. The production base features a 20,000 ㎡ plant with a production capacity of over 8,000 MT per year.
Mesochem Company Banner

04

Biotechnica DWC

Algeria
IOPC
Not Confirmed
arrow

Biotechnica DWC

Algeria
arrow
IOPC
Not Confirmed

Rituximab

About the Company : BIOTECHNICA DWC LLC has carved a niche for itself in providing value added compliance, regulatory qualification, project management and GDP guidance services to pharma companies al...

BIOTECHNICA DWC LLC has carved a niche for itself in providing value added compliance, regulatory qualification, project management and GDP guidance services to pharma companies all over the world. Biotechnica is an integrated global solution provider from design to implementation of industrial projects in the areas of Pharmaceuticals,Agri-food ,Cosmetics and Nutrition. With more than 25 years of experience in the assembly of plants, particularly in the pharmaceutical sector, we accompany our customers in the various stages of their projects – E-CTD Dossieers – Raw Materiels – Equipements – Accessories – Packaging – Distribution.
blank

05

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Rituximab

About the Company : Conscientia Industrial is a pharmaceutical company, mainly developing, manufacturing, marketing APIs (Active Pharmaceutical Ingredients), intermediates, fine chemicals in China. We...

Conscientia Industrial is a pharmaceutical company, mainly developing, manufacturing, marketing APIs (Active Pharmaceutical Ingredients), intermediates, fine chemicals in China. We started business in early 2010, producing and providing products for both human and veterinary health at home and abroad. Conscientia Industrial makes regular productions and also provides custom synthesis, contract manufacturing services. We have series of products, such as Hormones, Prostaglandins, Peptides, Anti-cancer, Anti-tumor, Anti-virus, Anti-diabetic APIs and their related intermediates, impurities, chemicals.
blank

06

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Rituximab

About the Company : The last few years have seen dramatic growth in outsourcing to India in all areas of technology. The trend has been particularly noticeable in the pharmaceuticals sector. Leading p...

The last few years have seen dramatic growth in outsourcing to India in all areas of technology. The trend has been particularly noticeable in the pharmaceuticals sector. Leading pharmaceutical firms across the world are increasingly turning to India to outsource processes and solutions as part of their efforts to bring down the price of drugs. Drug makers operating in US could save at least 60 per cent in producing new drugs by out sourcing R&D and other services to India; it is estimated. In this way, we come in to picture. DELPHIS PHARMA is pharma house which offers third-party manufacturing for domestic and export formulations.
blank

07

KinBio

Israel
IOPC
Not Confirmed
arrow

KinBio

Israel
arrow
IOPC
Not Confirmed

Rituximab

About the Company : KinBio is a rapidly growing biopharmaceutical company based in Rehovot, Israel, with its main focus on developing needed therapies as well as offering a wide range of CDMO services...

KinBio is a rapidly growing biopharmaceutical company based in Rehovot, Israel, with its main focus on developing needed therapies as well as offering a wide range of CDMO services – from concept to product. KinBio’s main focus is to pursue opportunities in the global pharmaceutical market. Augmented by a global group of affiliated companies, Kinbio specializes in research, development, manufacturing and commercialization of biopharmaceutical products. Kinbio’s commitment to top standard quality is inherent across the entire global organization, from our FDA approved cGMP sites to our state of the art R&D laboratories.
blank

08

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Rituximab

About the Company : Established in 1997, Nanogen Pharmaceutical Biotechnology JSC has been striving to become a world-class innovative biotechnology company in the pharmaceutical industry. We are pro...

Established in 1997, Nanogen Pharmaceutical Biotechnology JSC has been striving to become a world-class innovative biotechnology company in the pharmaceutical industry. We are proud to be the leading company in the Asia-Pacific region that successfully researched and developed Active Pharmaceutical Ingredients (APIs) and specific therapeutic products on the foundation of advanced recombinant DNA/protein technology.
blank

09

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Rituximab

About the Company : Established in 1997, Nanogen Pharmaceutical Biotechnology JSC has been striving to become a world-class innovative biotechnology company in the pharmaceutical industry. We are pro...

Established in 1997, Nanogen Pharmaceutical Biotechnology JSC has been striving to become a world-class innovative biotechnology company in the pharmaceutical industry. We are proud to be the leading company in the Asia-Pacific region that successfully researched and developed Active Pharmaceutical Ingredients (APIs) and specific therapeutic products on the foundation of advanced recombinant DNA/protein technology.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1642789800,"product":"RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONC","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"SHEREMETYEVO","customer":"JSC R-PHARM","customerCountry":"RUSSIA","quantity":"0.93","actualQuantity":"934.937","unit":"GMS","unitRateFc":"30000","totalValueFC":"362434.6","currency":"RUB","unitRateINR":28877.881611274341,"date":"22-Jan-2022","totalValueINR":"26999000","totalValueInUsd":"362434.6","indian_port":"HYDERABAD AIR","hs_no":"29379020","bill_no":"7658518","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1645727400,"product":"RITUXIMAB(R-DNA ORIGIN)BULK(QTY:139.720","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"HEALTHCARE PHARMACEUTICALS LTD","customerCountry":"BANGLADESH","quantity":"0.14","actualQuantity":"139.72","unit":"GMS","unitRateFc":"741","totalValueFC":"102152","currency":"USD","unitRateINR":54802.462066991124,"date":"25-Feb-2022","totalValueINR":"7657000","totalValueInUsd":"102152","indian_port":"HYDERABAD AIR","hs_no":"29379020","bill_no":"8501301","productDescription":"API","marketType":"","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1649356200,"product":"RITUXIMAB(R-DNA ORIGIN)BULK(QTY:139.720","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"HEALTHCARE PHARMACEUTICALS LTD","customerCountry":"BANGLADESH","quantity":"0.14","actualQuantity":"139.72","unit":"GMS","unitRateFc":"741","totalValueFC":"102387.2","currency":"USD","unitRateINR":55289.149728027485,"date":"08-Apr-2022","totalValueINR":"7725000","totalValueInUsd":"102387.2","indian_port":"HYDERABAD AIR","hs_no":"29379020","bill_no":"9567044","productDescription":"API","marketType":"","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1662575400,"product":"RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONC","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"JSC R-PHARM","customerCountry":"RUSSIA","quantity":"0.84","actualQuantity":"836.421","unit":"GMS","unitRateFc":"30000","totalValueFC":"382600.4","currency":"RUB","unitRateINR":36658.572656592791,"date":"08-Sep-2022","totalValueINR":"30662000","totalValueInUsd":"382600.4","indian_port":"HYDERABAD AIR","hs_no":"29379020","bill_no":"4055273","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1662575400,"product":"RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONC","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"JSC R-PHARM","customerCountry":"RUSSIA","quantity":"0.87","actualQuantity":"872.622","unit":"GMS","unitRateFc":"30000","totalValueFC":"412622.5","currency":"RUB","unitRateINR":37894.987749563959,"date":"08-Sep-2022","totalValueINR":"33068000","totalValueInUsd":"412622.5","indian_port":"HYDERABAD AIR","hs_no":"29379020","bill_no":"4048151","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1662575400,"product":"RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONC","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"JSC R-PHARM","customerCountry":"RUSSIA","quantity":"0.88","actualQuantity":"877.968","unit":"GMS","unitRateFc":"30000","totalValueFC":"401604.4","currency":"RUB","unitRateINR":36658.511471944308,"date":"08-Sep-2022","totalValueINR":"32185000","totalValueInUsd":"401604.4","indian_port":"HYDERABAD AIR","hs_no":"29379020","bill_no":"4055273","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1669919400,"product":"RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONC","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, CONTACT N","city":"HYDERABAD","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"JSC R-PHARM","customerCountry":"RUSSIA","quantity":"0.83","actualQuantity":"828.668","unit":"GMS","unitRateFc":"30000","totalValueFC":"395358.3","currency":"RUB","unitRateINR":39316.107295080779,"date":"02-Dec-2022","totalValueINR":"32580000","totalValueInUsd":"395358.3","indian_port":"HYDERABAD AIR","hs_no":"29379020","bill_no":"5876856","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, CONTACT N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1670005800,"product":"RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONC","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, CONTACT N","city":"HYDERABAD","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"JSC R-PHARM","customerCountry":"RUSSIA","quantity":"0.77","actualQuantity":"766.844","unit":"GMS","unitRateFc":"30000","totalValueFC":"365299.9","currency":"RUB","unitRateINR":39255.70259400869,"date":"03-Dec-2022","totalValueINR":"30103000","totalValueInUsd":"365299.9","indian_port":"HYDERABAD AIR","hs_no":"29379020","bill_no":"5908555","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, CONTACT N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1670869800,"product":"RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONC","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, CONTACT N","city":"HYDERABAD","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"JSC R-PHARM","customerCountry":"RUSSIA","quantity":"0.74","actualQuantity":"743.62","unit":"GMS","unitRateFc":"30000","totalValueFC":"351405.3","currency":"RUB","unitRateINR":38941.932707565691,"date":"13-Dec-2022","totalValueINR":"28958000","totalValueInUsd":"351405.3","indian_port":"HYDERABAD AIR","hs_no":"29379020","bill_no":"6113906","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, CONTACT N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1670869800,"product":"RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONC","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, CONTACT N","city":"HYDERABAD","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"JSC R-PHARM","customerCountry":"RUSSIA","quantity":"0.91","actualQuantity":"906.099","unit":"GMS","unitRateFc":"30000","totalValueFC":"428183.5","currency":"RUB","unitRateINR":38941.66090018861,"date":"13-Dec-2022","totalValueINR":"35285000","totalValueInUsd":"428183.5","indian_port":"HYDERABAD AIR","hs_no":"29379020","bill_no":"6113906","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, CONTACT N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q4","strtotime":1671474600,"product":"RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONC","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, CONTACT N","city":"HYDERABAD","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"MOSCOW DOMODEDOVO","customer":"JSC R-PHARM","customerCountry":"RUSSIA","quantity":"0.82","actualQuantity":"824.918","unit":"GMS","unitRateFc":"30000","totalValueFC":"373940","currency":"RUB","unitRateINR":37355.228034786487,"date":"20-Dec-2022","totalValueINR":"30815000","totalValueInUsd":"373940","indian_port":"HYDERABAD AIR","hs_no":"29379020","bill_no":"6288604","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, CONTACT N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1675881000,"product":"RITUXIMAB(R-DNA ORIGIN)BULK(QTY:139.821","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"HEALTHCARE PHARMACEUTICALS LTD","customerCountry":"BANGLADESH","quantity":"0.14","actualQuantity":"139.821","unit":"GMS","unitRateFc":"300","totalValueFC":"40513.4","currency":"USD","unitRateINR":23930.596977564172,"date":"09-Feb-2023","totalValueINR":"3346000","totalValueInUsd":"40513.4","indian_port":"HYDERABAD AIR","hs_no":"29379020","bill_no":"7675850","productDescription":"API","marketType":"","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1679250600,"product":"RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONC","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, CONTACT N","city":"HYDERABAD","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"VNUKOVO","customer":"JSC R-PHARM","customerCountry":"RUSSIA","quantity":"1.78","actualQuantity":"1778.535","unit":"GMS","unitRateFc":"30000","totalValueFC":"696945.2","currency":"RUB","unitRateINR":32231.021599237574,"date":"20-Mar-2023","totalValueINR":"57324000","totalValueInUsd":"696945.2","indian_port":"HYDERABAD AIR","hs_no":"29379020","bill_no":"8600814","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, CONTACT N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1679509800,"product":"RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONC","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, CONTACT N","city":"HYDERABAD","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"VNUKOVO","customer":"JSC R-PHARM","customerCountry":"RUSSIA","quantity":"2.15","actualQuantity":"2149.784","unit":"GMS","unitRateFc":"30000","totalValueFC":"833127","currency":"RUB","unitRateINR":31875.295378512445,"date":"23-Mar-2023","totalValueINR":"68525000","totalValueInUsd":"833127","indian_port":"HYDERABAD AIR","hs_no":"29379020","bill_no":"8696256","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, CONTACT N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1679596200,"product":"RITUXIMAB(R-DNA ORIGIN)BULK","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, CONTACT N","city":"HYDERABAD","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"HEALTHCARE PHARMACEUTICALS LTD","customerCountry":"BANGLADESH","quantity":"0.14","actualQuantity":"140","unit":"GMS","unitRateFc":"300","totalValueFC":"40996.8","currency":"USD","unitRateINR":24085.714285714286,"date":"24-Mar-2023","totalValueINR":"3372000","totalValueInUsd":"40996.8","indian_port":"HYDERABAD AIR","hs_no":"29379020","bill_no":"8721837","productDescription":"API","marketType":"","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, CONTACT N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1679682600,"product":"RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONC","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, CONTACT N","city":"HYDERABAD","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"VNUKOVO","customer":"JSC R-PHARM","customerCountry":"RUSSIA","quantity":"0.54","actualQuantity":"542.54","unit":"GMS","unitRateFc":"30000","totalValueFC":"212278.7","currency":"RUB","unitRateINR":32181.958933903494,"date":"25-Mar-2023","totalValueINR":"17460000","totalValueInUsd":"212278.7","indian_port":"HYDERABAD AIR","hs_no":"29379020","bill_no":"8761534","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, CONTACT N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1688927400,"product":"RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONC","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"VNUKOVO","customer":"JSC R-PHARM","customerCountry":"RUSSIA","quantity":"2.57","actualQuantity":"2574.8","unit":"GMS","unitRateFc":"30000","totalValueFC":"848514.4","currency":"RUB","unitRateINR":27085.210455180983,"date":"10-Jul-2023","totalValueINR":"69738999.88","totalValueInUsd":"848514.4","indian_port":"HYDERABAD AIR","hs_no":"29379020","bill_no":"0","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1689964200,"product":"RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONC","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"VNUKOVO","customer":"JSC R-PHARM","customerCountry":"RUSSIA","quantity":"2.36","actualQuantity":"2360.303","unit":"GMS","unitRateFc":"30000","totalValueFC":"781790.6","currency":"RUB","unitRateINR":27223.199576495055,"date":"22-Jul-2023","totalValueINR":"64254999.63","totalValueInUsd":"781790.6","indian_port":"HYDERABAD AIR","hs_no":"29379020","bill_no":"0","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1690396200,"product":"RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONC","address":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N","city":"HYDERABAD","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"VNUKOVO","customer":"JSC R-PHARM","customerCountry":"RUSSIA","quantity":"2.46","actualQuantity":"2461.451","unit":"GMS","unitRateFc":"30000","totalValueFC":"815237.7","currency":"RUB","unitRateINR":27221.342269255005,"date":"27-Jul-2023","totalValueINR":"67004000.15","totalValueInUsd":"815237.7","indian_port":"HYDERABAD AIR","hs_no":"29379020","bill_no":"0","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"H.NO. 8-2-337, BESIDE TV9 OFFICE, ROAD NO.3, BANJARA HILLS, Contact N, HYDERABAD","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1700677800,"product":"RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 20.5 MG\/ML WITH BUFFER SOLUTION 71,062 L(QTY:1456.771 GMS)","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"VNUKOVO","customer":"JSC R-PHARM","customerCountry":"RUSSIA","quantity":"1.46","actualQuantity":"1456.771","unit":"GMS","unitRateFc":"30000","totalValueFC":"486448.6","currency":"RUB","unitRateINR":27806.017555264349,"date":"23-Nov-2023","totalValueINR":"40507000","totalValueInUsd":"486448.6","indian_port":"Hyderabad Air","hs_no":"29379020","bill_no":"5517004","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703529000,"product":"RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 21 MG\/ML WITH BUFFER SOLUTION41,884 L(QTY:879.564 GMS)","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"VNUKOVO","customer":"JSC R-PHARM","customerCountry":"RUSSIA","quantity":"0.88","actualQuantity":"879.564","unit":"GMS","unitRateFc":"30000","totalValueFC":"281837","currency":"RUB","unitRateINR":26673.442751181268,"date":"26-Dec-2023","totalValueINR":"23461000","totalValueInUsd":"281837","indian_port":"Hyderabad Air","hs_no":"29379020","bill_no":"6297166","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1710786600,"product":"RITUXIMAB SUBSTANCE FROZEN SOLUTION CONCENTRATION 20 MG\/ML WITH BUFFER SOLUTION72,828 L(QTY:1456.560 GMS)","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"VNUKOVO","customer":"JSC R PHARM","customerCountry":"RUSSIA","quantity":"1.46","actualQuantity":"1456.56","unit":"GMS","unitRateFc":"30000","totalValueFC":"467392.4","currency":"RUB","unitRateINR":26645.173786181138,"date":"19-Mar-2024","totalValueINR":"38810294.33","totalValueInUsd":"467392.4","indian_port":"Hyderabad Air","hs_no":"29379020","bill_no":"8442733","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1710786600,"product":"RITUXIMAB SUBSTANCE FROZEN SOLUTION CONCENTRATION 20.3 MG\/ML WITH BUFFER SOLUTION 106,101 L(QTY:2153.850 GMS)","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"VNUKOVO","customer":"JSC R PHARM","customerCountry":"RUSSIA","quantity":"2.15","actualQuantity":"2153.85","unit":"GMS","unitRateFc":"30000","totalValueFC":"691144.3","currency":"RUB","unitRateINR":26645.174352902945,"date":"19-Mar-2024","totalValueINR":"57389708.78","totalValueInUsd":"691144.3","indian_port":"Hyderabad Air","hs_no":"29379020","bill_no":"8442733","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1711564200,"product":"RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 20.3 MG\/ML WITH BUFFER SOLUTION 111,234 L(QTY:2258.050 GMS)","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"VNUKOVO","customer":"JSC R-PHARM","customerCountry":"RUSSIA","quantity":"2.26","actualQuantity":"2258.05","unit":"GMS","unitRateFc":"30000","totalValueFC":"730030.9","currency":"RUB","unitRateINR":26845.594756537721,"date":"28-Mar-2024","totalValueINR":"60618695.24","totalValueInUsd":"730030.9","indian_port":"Hyderabad Air","hs_no":"29379020","bill_no":"8700959","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1715193000,"product":"RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 21.1 MG\/ML WITH BUFFER SOLUTION 115,424 L(QTY:2435.446 GMS)","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"VNUKOVO","customer":"JSC R-PHARM","customerCountry":"RUSSIA","quantity":"2.44","actualQuantity":"2435.446","unit":"GMS","unitRateFc":"30000","totalValueFC":"792033.8","currency":"RUB","unitRateINR":27107.692246101946,"date":"09-May-2024","totalValueINR":"66019320.65","totalValueInUsd":"792033.8","indian_port":"Hyderabad Air","hs_no":"29379020","bill_no":"9743470","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q2","strtotime":1718994600,"product":"RITUXIMAB(R-DNA ORIGIN)BULK(QTY:280 GMS)","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"DHAKA","customer":"HEALTHCARE PHARMACEUTICALS LTD","customerCountry":"BANGLADESH","quantity":"0.28","actualQuantity":"280","unit":"GMS","unitRateFc":"300","totalValueFC":"80861.2","currency":"USD","unitRateINR":24108.010642857145,"date":"22-Jun-2024","totalValueINR":"6750242.98","totalValueInUsd":"80861.2","indian_port":"Hyderabad Air","hs_no":"29379020","bill_no":"1861805","productDescription":"API","marketType":"","country":"BANGLADESH","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1733077800,"product":"RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 20.1 MG\/ML WITH BUFFER SOLUTION 95,273 L(QTY:1914.9873 GMS)","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"VNUKOVO","customer":"JSC R-PHARM","customerCountry":"RUSSIA","quantity":"1.91","actualQuantity":"1914.987","unit":"GMS","unitRateFc":"30000","totalValueFC":"522493.3","currency":"RUB","unitRateINR":23183.302053747622,"date":"02-Dec-2024","totalValueINR":"44395722.05","totalValueInUsd":"522493.3","indian_port":"Hyderabad Air","hs_no":"29379020","bill_no":"6103699","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q4","strtotime":1733077800,"product":"RITUXIMAB SUBSTANCE-FROZEN SOLUTION CONCENTRATION 21.5 MG\/ML WITH BUFFER SOLUTION 121,371 L(QTY:2609.4765 GMS)","address":"H.NO. 8-2-337,BESIDE TV9 OFFICE","city":"HYDERABAD ANDHRA PRADESH","supplier":"DRREDDY\\'S LABORATORIES LTD","supplierCountry":"INDIA","foreign_port":"VNUKOVO","customer":"JSC R-PHARM","customerCountry":"RUSSIA","quantity":"2.61","actualQuantity":"2609.476","unit":"GMS","unitRateFc":"30000","totalValueFC":"724603.2","currency":"RUB","unitRateINR":23594.314544375957,"date":"02-Dec-2024","totalValueINR":"61568797.54","totalValueInUsd":"724603.2","indian_port":"Hyderabad Air","hs_no":"29379020","bill_no":"6103689","productDescription":"API","marketType":"","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"H.NO. 8-2-337,BESIDE TV9 OFFICE, HYDERABAD ANDHRA PRADESH","customerAddress":""}]
22-Jan-2022
02-Dec-2024
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

read-more
read-more

Details:

Tepkinly (epcoritamab) is an IgG1-bispecific antibody, which is evaluated for the treatment of diffuse large B-cell lymphoma. It is designed to direct cytotoxic T cells selectively.


Lead Product(s): Epcoritamab,Cyclophosphamide,Rituximab

Therapeutic Area: Oncology Brand Name: Tepkinly

Study Phase: Phase IIIProduct Type: Antibody

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 09, 2024

Abbvie Company Banner

01

AbbVie Inc

U.S.A
arrow

Details : Tepkinly (epcoritamab) is an IgG1-bispecific antibody, which is evaluated for the treatment of diffuse large B-cell lymphoma. It is designed to direct cytotoxic T cells selectively.

Product Name : Tepkinly

Product Type : Antibody

Upfront Cash : Inapplicable

December 09, 2024

Abbvie Company Banner

Details:

Updates are based on more than five years of Phase 3 iNNOVATE final analysis data, which demonstrated IMBRUVICA plus rituximab significantly prolonged progression-free survival (PFS) versus rituximab alone in adults with WM.


Lead Product(s): Ibrutinib,Rituximab

Therapeutic Area: Oncology Brand Name: Imbruvica

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 23, 2020

Abbvie Company Banner

02

AbbVie Inc

U.S.A
arrow

Details : Updates are based on more than five years of Phase 3 iNNOVATE final analysis data, which demonstrated IMBRUVICA plus rituximab significantly prolonged progression-free survival (PFS) versus rituximab alone in adults with WM.

Product Name : Imbruvica

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

December 23, 2020

Abbvie Company Banner

Details:

Submission is based on results of more than five years of follow-up data from the Phase 3 iNNOVATE clinical trial evaluating IMBRUVICA in combination with rituximab for patients with WM. This is the longest follow-up data available for a BTK inhibitor in WM.


Lead Product(s): Ibrutinib,Rituximab

Therapeutic Area: Oncology Brand Name: Imbruvica

Study Phase: Approved FDFProduct Type: Other Small Molecule

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable June 23, 2020

Abbvie Company Banner

03

AbbVie Inc

U.S.A
arrow

Details : Submission is based on results of more than five years of follow-up data from the Phase 3 iNNOVATE clinical trial evaluating IMBRUVICA in combination with rituximab for patients with WM. This is the longest follow-up data available for a BTK inhibitor in...

Product Name : Imbruvica

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

June 23, 2020

Abbvie Company Banner

Details:

Phase 3 MURANO trial shows median progression-free survival of 53.6 months in previously treated CLL patients taking VENCLEXTA/VENCLYXTO in combination with rituximab Vs. 17.0 months in patients taking bendamustine plus rituximab after three years or more off treatment.


Lead Product(s): Venetoclax,Rituximab

Therapeutic Area: Oncology Brand Name: Venclexta

Study Phase: Phase IIIProduct Type: Other Small Molecule

Sponsor: F. Hoffmann-La Roche

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 12, 2020

Abbvie Company Banner

04

AbbVie Inc

U.S.A
arrow

Details : Phase 3 MURANO trial shows median progression-free survival of 53.6 months in previously treated CLL patients taking VENCLEXTA/VENCLYXTO in combination with rituximab Vs. 17.0 months in patients taking bendamustine plus rituximab after three years or mor...

Product Name : Venclexta

Product Type : Other Small Molecule

Upfront Cash : Inapplicable

May 12, 2020

Abbvie Company Banner

Details:

Ituxredi (rituximab) is an anti-CD20 monoclonal antibody, which is indicated for the treatment of non-hodgkin’s lymphoma, chronic lymphocytic leukemia & rheumatoid arthritis.


Lead Product(s): Rituximab

Therapeutic Area: Oncology Brand Name: Ituxredi

Study Phase: Phase IIIProduct Type: Antibody

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable July 29, 2024

Dr Reddy Company Banner

05

Lead Product(s) : Rituximab

Therapeutic Area : Oncology

Highest Development Status : Phase III

Partner/Sponsor/Collaborator : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : Ituxredi (rituximab) is an anti-CD20 monoclonal antibody, which is indicated for the treatment of non-hodgkin’s lymphoma, chronic lymphocytic leukemia & rheumatoid arthritis.

Product Name : Ituxredi

Product Type : Antibody

Upfront Cash : Inapplicable

July 29, 2024

Dr Reddy Company Banner

Details:

DRL_RI is being developed as a biosimilar of Rituxan/MabThera (rituximab), a CD20 directed cytolytic antibody for various indications including treatment of adult patients with rheumatoid arthritis, non-Hodgkin's lymphoma, chronic lymphocytic leukaemia, and pemphigus vulgaris.


Lead Product(s): Rituximab

Therapeutic Area: Immunology Brand Name: Ituxredi

Study Phase: Phase IIIProduct Type: Antibody

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable December 07, 2023

Dr Reddy Company Banner

06

Lead Product(s) : Rituximab

Therapeutic Area : Immunology

Highest Development Status : Phase III

Partner/Sponsor/Collaborator : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : DRL_RI is being developed as a biosimilar of Rituxan/MabThera (rituximab), a CD20 directed cytolytic antibody for various indications including treatment of adult patients with rheumatoid arthritis, non-Hodgkin's lymphoma, chronic lymphocytic leukaemia, ...

Product Name : Ituxredi

Product Type : Antibody

Upfront Cash : Inapplicable

December 07, 2023

Dr Reddy Company Banner

Details:

DRL_RI is being developed as a biosimilar of rituximab, CD20 directed cytolytic antibody for various indications including treatment of adult patients with rheumatoid arthritis, non-Hodgkin's lymphoma, chronic lymphocytic leukaemia, pemphigus vulgaris etc.


Lead Product(s): Rituximab

Therapeutic Area: Oncology Brand Name: Ituxredi

Study Phase: Phase IIIProduct Type: Antibody

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable January 19, 2023

Dr Reddy Company Banner

07

Lead Product(s) : Rituximab

Therapeutic Area : Oncology

Highest Development Status : Phase III

Partner/Sponsor/Collaborator : Inapplicable

Deal Size : Inapplicable

Deal Type : Inapplicable

Details : DRL_RI is being developed as a biosimilar of rituximab, CD20 directed cytolytic antibody for various indications including treatment of adult patients with rheumatoid arthritis, non-Hodgkin's lymphoma, chronic lymphocytic leukaemia, pemphigus vulgaris et...

Product Name : Ituxredi

Product Type : Antibody

Upfront Cash : Inapplicable

January 19, 2023

Dr Reddy Company Banner

Details:

PTG-007 is a Treg therapy, which is currently being evaluated for preventing symptomatic type 1 diabetes in children.


Lead Product(s): PTG-007,Rituximab

Therapeutic Area: Endocrinology Brand Name: PTG-007

Study Phase: Phase IIProduct Type: Cell and Gene therapy

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 15, 2025

blank

08

PolTREG

Poland
arrow
IOPC
Not Confirmed

PolTREG

Poland
arrow
IOPC
Not Confirmed

Details : PTG-007 is a Treg therapy, which is currently being evaluated for preventing symptomatic type 1 diabetes in children.

Product Name : PTG-007

Product Type : Cell and Gene therapy

Upfront Cash : Inapplicable

May 15, 2025

blank

Details:

BI-1206, an antibody targeting FcγRIIB, given in combination with rituximab and acalabrutinib is being evaluated in subjects with indolent B-cell non-hodgkin's lymphoma.


Lead Product(s): BI-1206,Acalabrutinib,Rituximab

Therapeutic Area: Oncology Brand Name: BI-1206

Study Phase: Phase I/ Phase IIProduct Type: Antibody

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 14, 2025

blank

09

BioInvent

Sweden
arrow
IOPC
Not Confirmed

BioInvent

Sweden
arrow
IOPC
Not Confirmed

Details : BI-1206, an antibody targeting FcγRIIB, given in combination with rituximab and acalabrutinib is being evaluated in subjects with indolent B-cell non-hodgkin's lymphoma.

Product Name : BI-1206

Product Type : Antibody

Upfront Cash : Inapplicable

May 14, 2025

blank

Details:

Epkinly (epcoritamab) is a bispecific CD20/CD3 T-cell engager therapy being investigated for adult patients with relapsed/refractory follicular lymphoma in combination with rituximab and lenalidomide.


Lead Product(s): Epcoritamab,Lenalidomide,Rituximab

Therapeutic Area: Oncology Brand Name: Epkinly

Study Phase: Phase IIIProduct Type: Antibody

Sponsor: Inapplicable

Deal Size: Inapplicable Upfront Cash: Inapplicable

Deal Type: Inapplicable May 01, 2025

blank

10

Genmab

Denmark
arrow
IOPC
Not Confirmed

Genmab

Denmark
arrow
IOPC
Not Confirmed

Details : Epkinly (epcoritamab) is a bispecific CD20/CD3 T-cell engager therapy being investigated for adult patients with relapsed/refractory follicular lymphoma in combination with rituximab and lenalidomide.

Product Name : Epkinly

Product Type : Antibody

Upfront Cash : Inapplicable

May 01, 2025

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

read-more
read-more

01

Aprogen

South Korea
IOPC
Not Confirmed
arrow

Aprogen

South Korea
arrow
IOPC
Not Confirmed

Rituximab

Brand Name :

Dosage Form :

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : South Korea

blank

02

Celltrion

South Korea
IOPC
Not Confirmed
arrow

Celltrion

South Korea
arrow
IOPC
Not Confirmed

RITUXIMAB

Brand Name : TRUXIMA

Dosage Form : SOLUTION

Dosage Strength : 100MG/10ML

Packaging : 10 ML

Approval Date :

Application Number : 2478382

Regulatory Info : Prescription

Registration Country : Canada

blank

03

Celltrion

South Korea
IOPC
Not Confirmed
arrow

Celltrion

South Korea
arrow
IOPC
Not Confirmed

Rituximab

Brand Name : Truxima

Dosage Form :

Dosage Strength :

Packaging : 2

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

04

Celltrion

South Korea
IOPC
Not Confirmed
arrow

Celltrion

South Korea
arrow
IOPC
Not Confirmed

Rituximab

Brand Name : Truxima

Dosage Form :

Dosage Strength :

Packaging : 2

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

05

F. Hoffmann-La Roche

Switzerland
IOPC
Not Confirmed
arrow

F. Hoffmann-La Roche

Switzerland
arrow
IOPC
Not Confirmed

Rituximab

Brand Name : Mabthera

Dosage Form : Rituximab 500Mg 50Ml 1 Units Parenteral Use

Dosage Strength : 1 vial EV 500 mg 50 ml 10 mg/ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Italy

blank

06

F. Hoffmann-La Roche

Switzerland
IOPC
Not Confirmed
arrow

F. Hoffmann-La Roche

Switzerland
arrow
IOPC
Not Confirmed

Rituximabum

Brand Name : MabThera subcutane

Dosage Form : Inj L?s

Dosage Strength : 1600mg/13.4ml

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Switzerland

blank

07

F. Hoffmann-La Roche

Switzerland
IOPC
Not Confirmed
arrow

F. Hoffmann-La Roche

Switzerland
arrow
IOPC
Not Confirmed

Rituximab

Brand Name : RISTOVA® 500

Dosage Form : INF

Dosage Strength : 10mg/ml

Packaging : 50X1mg/ml

Approval Date :

Application Number :

Regulatory Info : Generic

Registration Country : South Africa

blank

08

Genentech

U.S.A
IOPC
Not Confirmed
arrow

Genentech

U.S.A
arrow
IOPC
Not Confirmed

RITUXIMAB

Brand Name : RITUXAN

Dosage Form : SOLUTION;INTRAVENOUS

Dosage Strength : 500MG/50ML (10MG/ML)

Packaging :

Approval Date :

Application Number : 103705

Regulatory Info :

Registration Country : USA

blank

09

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Rituximab

Brand Name : Ruxience

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

10

Pfizer Inc

U.S.A
IOPC
Not Confirmed
arrow

Pfizer Inc

U.S.A
arrow
IOPC
Not Confirmed

RITUXIMAB-PVVR

Brand Name : RUXIENCE

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 100MG/10ML(10MG/ML)

Packaging :

Approval Date :

Application Number : 761103

Regulatory Info :

Registration Country : USA

blank
click full view
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

read-more
read-more

01

Aprogen

South Korea
IOPC
Not Confirmed
arrow

Aprogen

South Korea
arrow
IOPC
Not Confirmed

Rituximab

Brand Name :

Dosage Form :

Dosage Strength :

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : South Korea

blank

01

Aprogen

South Korea
IOPC
Not Confirmed
arrow

Aprogen

South Korea
arrow
IOPC
Not Confirmed

Rituximab

Dosage :

Dosage Strength :

Brand Name :

Approval Date :

Application Number :

Registration Country : South Korea

blank

02

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Rituximab

Brand Name : Zytux

Dosage Form : Injectable

Dosage Strength : 100MG

Packaging : Vial

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

blank

02

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Rituximab

Dosage : Injectable

Dosage Strength : 100MG

Brand Name : Zytux

Approval Date :

Application Number :

Registration Country : Iran

blank

03

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Rituximab

Brand Name : Zytux

Dosage Form : Injectable

Dosage Strength : 500MG

Packaging : Vial

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Iran

blank

03

IOPC
Not Confirmed
arrow
arrow
IOPC
Not Confirmed

Rituximab

Dosage : Injectable

Dosage Strength : 500MG

Brand Name : Zytux

Approval Date :

Application Number :

Registration Country : Iran

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Solubilizers

read-more
read-more

Parenteral

read-more
read-more

Topical

read-more
read-more

Emulsifying Agents

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Controlled & Modified Release

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Co-Processed Excipients

read-more
read-more

Direct Compression

read-more
read-more

Taste Masking

read-more
read-more

Rheology Modifiers

read-more
read-more

API Stability Enhancers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

STOCK RECAP #PipelineProspector

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty